<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In order to observe the expression of Fas, FasL and Bcl-2 and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of bone marrow CD34(+) cells in patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), and to explore the relation between the expression of these antigens and <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, the expression of Fas, FasL and Bcl-2 and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of bone marrow CD34(+) cell were evaluated by flow cytometry in 26 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> including 9 cases of refactory <z:hpo ids='HP_0001903'>anemia</z:hpo> (RA), 1 case of RA with ringed sideroblasts (<z:mp ids='MP_0011356'>RAS</z:mp>), 9 cases of RA with excess blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>) and 7 cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> in transformation (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t), 10 patients with <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) and 6 control patients with <z:mpath ids='MPATH_458'>normal</z:mpath> bone marrow </plain></SENT>
<SENT sid="1" pm="."><plain>The results showed that the expression of Fas and FasL of CD34(+) cells significantly increased in <z:hpo ids='HP_0000001'>all</z:hpo> types of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients compared with control group (P &lt; 0.01) </plain></SENT>
<SENT sid="2" pm="."><plain>The expression of Bcl-2 on CD34(+) cells in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t patients was much higher as compared with that in control group (P &lt; 0.01), but there was no significant difference between RA/<z:mp ids='MP_0011356'>RAS</z:mp> patients and control group (P &gt; 0.05) </plain></SENT>
<SENT sid="3" pm="."><plain>The expression rates of Fas on CD34(+) cells were almost identical in <z:hpo ids='HP_0000001'>all</z:hpo> kinds of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, but there was significant difference on the expression of Bcl-2 (RA/<z:mp ids='MP_0011356'>RAS</z:mp> &lt; <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> &lt; <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t) </plain></SENT>
<SENT sid="4" pm="."><plain><z:mpath ids='MPATH_3'>Apoptosis</z:mpath> of CD34(+) cells significantly increased in RA/<z:mp ids='MP_0011356'>RAS</z:mp> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> patients compared with control group (P &lt; 0.01), but there was no difference between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t and control group </plain></SENT>
<SENT sid="5" pm="."><plain>Moreover, <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of CD34(+) cells in control much higher than that in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> group (P &lt; 0.01) </plain></SENT>
<SENT sid="6" pm="."><plain>There was no correlation between the expression of Fas or FasL and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> on CD34(+) cell of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients </plain></SENT>
<SENT sid="7" pm="."><plain>Nevertheless, there was a negative correlation between the expression of Bcl-2 and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>It is concluded that <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of CD34(+) cells was affected by a lot of factors in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, in which Bcl-2 is an important factor of depressing <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="9" pm="."><plain>During the progress from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, <z:mpath ids='MPATH_3'>apoptosis</z:mpath> changes from overgoing to deficiency in CD34(+) cell </plain></SENT>
</text></document>